v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Cash Flow Activities:    
Net loss $ (27,404) $ (26,441)
Reconciliation of net loss to net cash used in operating activities    
Depreciation 76 151
Accretion of debt discount and amortization of financing costs 1,276 743
Change in fair value of derivative liabilities (1,125) (7,222)
Stock-based compensation expense 793 1,736
Payable-in-kind interest on Credit Agreement 3,409 5,433
Operating lease right-of-use assets 56 160
Changes in operating assets and liabilities    
Accounts receivable 151 114
Inventory 239 173
Prepaid expenses and other current assets 639 673
Accounts payable, accrued expenses, due to related parties, and other current liabilities 4,048 45
Operating lease liabilities (65) (183)
Net cash used in operating activities (17,907) (24,618)
Investing Cash Flow Activities:    
Purchases of equipment and leasehold improvements 0 0
Net cash from investing activities 0 0
Financing Cash Flow Activities:    
Proceeds from issuance of common stock and warrants 11,607 14,146
Payment of principal of Long-term debt (8,412) 0
Offering costs for common stock and warrants issuance (220) (806)
Payment of employee tax obligations related to vesting restricted stock units (24) (1)
Net cash provided by financing activities 2,951 13,339
Net (decrease) in cash, cash equivalents and restricted cash (14,956) (11,279)
Cash, cash equivalents and restricted cash, beginning of the period 28,757 29,854
Cash, cash equivalents and restricted cash, end of the period 13,801 18,575
Balance sheet reconciliation:    
Cash and cash equivalents 12,841 17,435
Restricted cash 960 1,140
Total cash and cash equivalents and restricted cash as presented above 13,801 18,575
Supplemental cash flow information:    
Issuance of stock purchase warrants 7,587 0
Repricing of stock purchase warrants 506 0
Interest paid $ 3,651 $ 0